Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Adoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myeloma.

Meehan KR, Talebian L, Tosteson TD, Hill JM, Szczepiorkowski Z, Sentman CL, Ernstoff MS.

Biol Blood Marrow Transplant. 2013 Jan;19(1):129-37. doi: 10.1016/j.bbmt.2012.08.018. Epub 2012 Sep 10.

2.

The natural killer-activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cells.

Talebian L, Fischer DA, Wu J, Channon JY, Sentman CL, Ernstoff MS, Meehan KR.

Transfusion. 2014 Jun;54(6):1515-21. doi: 10.1111/trf.12517. Epub 2014 Jan 22.

PMID:
24446786
3.

Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma.

Wu JY, Ernstoff MS, Hill JM, Cole B, Meehan KR.

Cytotherapy. 2006;8(2):141-8.

PMID:
16698687
4.

Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.

Li WX, Pan HF, Hu JL, Wang CZ, Zhang N, Li J, Li XP, Xu JH, Ye DQ.

Clin Rheumatol. 2010 Mar;29(3):315-23. doi: 10.1007/s10067-009-1322-9. Epub 2009 Dec 10.

PMID:
20012119
5.

Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.

Santin AD, Bellone S, Palmieri M, Bossini B, Dunn D, Roman JJ, Pecorelli S, Cannon M, Parham GP.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1345-55.

PMID:
12459356
6.

Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.

Ge X, Li CR, Yang J, Wang GB.

Scand J Immunol. 2013 May;77(5):389-97. doi: 10.1111/sji.12022.

7.

Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.

Rapoport AP, Stadtmauer EA, Aqui N, Vogl D, Chew A, Fang HB, Janofsky S, Yager K, Veloso E, Zheng Z, Milliron T, Westphal S, Cotte J, Huynh H, Cannon A, Yanovich S, Akpek G, Tan M, Virts K, Ruehle K, Harris C, Philip S, Vonderheide RH, Levine BL, June CH.

Clin Cancer Res. 2009 Jul 1;15(13):4499-507. doi: 10.1158/1078-0432.CCR-09-0418. Epub 2009 Jun 9.

8.
9.

Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.

von Lilienfeld-Toal M, Frank S, Leyendecker C, Feyler S, Jarmin S, Morgan R, Glasmacher A, Märten A, Schmidt-Wolf IG, Brossart P, Cook G.

Cancer Immunol Immunother. 2010 Jun;59(6):829-39. doi: 10.1007/s00262-009-0807-3. Epub 2009 Dec 19.

PMID:
20024547
10.
11.

Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants.

Rutella S, Rumi C, Laurenti L, Pierelli L, Sora' F, Sica S, Leone G.

Br J Haematol. 2000 Jan;108(1):105-15.

PMID:
10651733
13.

Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma.

Meehan KR, Wu J, Bengtson E, Hill J, Ely P, Szczepiorkowski Z, Kendall M, Ernstoff MS.

Bone Marrow Transplant. 2007 Jun;39(11):695-703. Epub 2007 Apr 9.

PMID:
17417660
14.

Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.

Karimi M, Cao TM, Baker JA, Verneris MR, Soares L, Negrin RS.

J Immunol. 2005 Dec 15;175(12):7819-28.

15.
16.

Detuning CD8+ T lymphocytes by down-regulation of the activating receptor NKG2D: role of NKG2D ligands released by activated T cells.

Cerboni C, Ardolino M, Santoni A, Zingoni A.

Blood. 2009 Mar 26;113(13):2955-64. doi: 10.1182/blood-2008-06-165944. Epub 2009 Jan 5.

17.

[Immune reconstitution after autologous progenitor hemopoietic cell transplantation. A study comparing autologous bone marrow and autologous peripheral blood transplantation].

Hernández MD, del Cañizo MC, González M, Caballero MD, López-Berges MC, Vázquez L, Orfao A, Corral M, Nieto MJ, San Miguel JF.

Med Clin (Barc). 1998 Jun 6;110(20):768-73. Spanish.

PMID:
9666417
18.

Lymphocyte subset analysis for the assessment of treatment-related complications after autologous stem cell transplantation in multiple myeloma.

Lee SE, Yahng SA, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Kim DW, Lee JW, Min WS, Park CW, Min CK.

Cytotherapy. 2012 Apr;14(4):505-12. doi: 10.3109/14653249.2012.655421. Epub 2012 Feb 6.

PMID:
22309319
19.

Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival.

Koehl U, Bochennek K, Zimmermann SY, Lehrnbecher T, Sörensen J, Esser R, Andreas C, Kramm C, Grüttner HP, Falkenberg E, Orth A, Bader P, Schwabe D, Klingebiel T.

Bone Marrow Transplant. 2007 Mar;39(5):269-78.

PMID:
17311085
20.

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.

Verneris MR, Karimi M, Baker J, Jayaswal A, Negrin RS.

Blood. 2004 Apr 15;103(8):3065-72. Epub 2003 Nov 20. Erratum in: Blood. 2015 Apr 16;125(16):2583. Karami, Mobin [corrected to Karimi, Mobin].

Supplemental Content

Support Center